Overview
Stephanie Dublis is a Hematologist Oncology specialist and a Hematologist in Sparta, Michigan. Dr. Dublis is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma of the Scalp. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Dublis is currently accepting new patients.
Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2111 12 Mile Rd Nw, Sparta, MI 49345
100 Michigan Ave Ne, Grand Rapids, MI 49503
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Spectrum Health Primary Care Partners
Mohammad Alhyari is an Oncologist and a Hematologist in Grand Rapids, Michigan. Dr. Alhyari is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma of the Scalp. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Alhyari is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Dublis isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Dublis isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Dublis isDistinguished. Learn about Lung Cancer.
- Myelodysplastic Syndrome (MDS)Dr. Dublis isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Paget Disease of the BreastDr. Dublis isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Dublis isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Autoimmune Hemolytic AnemiaDr. Dublis isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Dublis isAdvanced. Learn about Breast Cancer.
- Chronic Myelogenous Leukemia (CML)
- Colorectal CancerDr. Dublis isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Dublis isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Mountain SicknessDr. Dublis isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Dublis isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaDr. Dublis isExperienced. Learn about Adenoid Cystic Carcinoma.